Lumexa Imaging (LMRI) Competitors

$9.73 -0.46 (-4.51%)

Closing price 04:00 PM Eastern

Extended Trading

$9.74 +0.01 (+0.10%)

As of 04:04 PM Eastern

LMRI vs. PRVA, CON, HTFL, LFST, and VCYT

Should you be buying Lumexa Imaging stock or one of its competitors? The main competitors of Lumexa Imaging include Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), Heartflow (HTFL), LifeStance Health Group (LFST), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

How does Lumexa Imaging compare to Privia Health Group?

Lumexa Imaging (NASDAQ:LMRI) and Privia Health Group (NASDAQ:PRVA) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.

: Lumexa Imaging currently has a consensus target price of $19.00, indicating a potential upside of 95.27%. Privia Health Group has a consensus target price of $31.31, indicating a potential upside of 28.89%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, equities analysts plainly believe Lumexa Imaging is more favorable than Privia Health Group.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lumexa Imaging
0 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

1 Strong Buy rating(s)
3.50
Privia Health Group
0 Sell rating(s)

3 Hold rating(s)

11 Buy rating(s)

0 Strong Buy rating(s)
2.79
: Privia Health Group has higher revenue and earnings than Lumexa Imaging.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Lumexa Imaging $267.73M 3.49 N/A N/A N/A
Privia Health Group $2.12B 1.44 $22.92M $0.17 142.88
: Privia Health Group has a net margin of 1.08% compared to Lumexa Imaging's net margin of 0.00%. Privia Health Group's return on equity of 3.06% beat Lumexa Imaging's return on equity.
Company Net Margins Return on Equity Return on Assets
Lumexa Imaging N/A N/A N/A
Privia Health Group 1.08% 3.06% 1.77%
: In the previous week, Privia Health Group had 4 more articles in the media than Lumexa Imaging. MarketBeat recorded 4 mentions for Privia Health Group and 0 mentions for Lumexa Imaging. Privia Health Group's average media sentiment score of 0.16 beat Lumexa Imaging's score of 0.00 indicating that Privia Health Group is being referred to more favorably in the news media.
Company Overall Sentiment
Lumexa Imaging Neutral
Privia Health Group Neutral
: 94.5% of Privia Health Group shares are held by institutional investors. 5.7% of Privia Health Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$267.73M	3.49	N/A	N/A	N/A
Privia Health Group	$2.12B	1.44	$22.92M	$0.17	142.88

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
Privia Health Group	1.08%	3.06%	1.77%

Company	Overall Sentiment
Lumexa Imaging	Neutral
Privia Health Group	Neutral

Summary

Privia Health Group beats Lumexa Imaging on 9 of the 13 factors compared between the two stocks.

How does Lumexa Imaging compare to Concentra Group Holdings Parent?

Concentra Group Holdings Parent (NYSE:CON) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

: In the previous week, Concentra Group Holdings Parent had 6 more articles in the media than Lumexa Imaging. MarketBeat recorded 6 mentions for Concentra Group Holdings Parent and 0 mentions for Lumexa Imaging. Concentra Group Holdings Parent's average media sentiment score of 0.71 beat Lumexa Imaging's score of 0.00 indicating that Concentra Group Holdings Parent is being referred to more favorably in the media.
Company Overall Sentiment
Concentra Group Holdings Parent Positive
Lumexa Imaging Neutral
: Concentra Group Holdings Parent has higher revenue and earnings than Lumexa Imaging.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Concentra Group Holdings Parent $2.16B 1.36 $166.41M $1.30 17.56
Lumexa Imaging $267.73M 3.49 N/A N/A N/A
: Concentra Group Holdings Parent presently has a consensus price target of $30.00, suggesting a potential upside of 31.44%. Lumexa Imaging has a consensus price target of $19.00, suggesting a potential upside of 95.27%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Lumexa Imaging is more favorable than Concentra Group Holdings Parent.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concentra Group Holdings Parent
0 Sell rating(s)
2 Hold rating(s)

3 Buy rating(s)

0 Strong Buy rating(s)
2.60
Lumexa Imaging
0 Sell rating(s)

0 Hold rating(s)

1 Buy rating(s)

1 Strong Buy rating(s)
3.50
: Concentra Group Holdings Parent has a net margin of 7.69% compared to Lumexa Imaging's net margin of 0.00%. Concentra Group Holdings Parent's return on equity of 48.46% beat Lumexa Imaging's return on equity.
Company Net Margins Return on Equity Return on Assets
Concentra Group Holdings Parent 7.69% 48.46% 6.24%
Lumexa Imaging N/A N/A N/A

Company	Overall Sentiment
Concentra Group Holdings Parent	Positive
Lumexa Imaging	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Concentra Group Holdings Parent	$2.16B	1.36	$166.41M	$1.30	17.56
Lumexa Imaging	$267.73M	3.49	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Concentra Group Holdings Parent	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Lumexa Imaging	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50

Company	Net Margins	Return on Equity	Return on Assets
Concentra Group Holdings Parent	7.69%	48.46%	6.24%
Lumexa Imaging	N/A	N/A	N/A

Summary

Concentra Group Holdings Parent beats Lumexa Imaging on 7 of the 11 factors compared between the two stocks.

How does Lumexa Imaging compare to Heartflow?

Lumexa Imaging (NASDAQ:LMRI) and Heartflow (NASDAQ:HTFL) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

: Lumexa Imaging has higher revenue and earnings than Heartflow.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Lumexa Imaging $267.73M 3.49 N/A N/A N/A
Heartflow $176.03M 14.68 -$116.79M -$1.99 N/A
: Lumexa Imaging currently has a consensus price target of $19.00, suggesting a potential upside of 95.27%. Heartflow has a consensus price target of $37.67, suggesting a potential upside of 25.72%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, equities analysts plainly believe Lumexa Imaging is more favorable than Heartflow.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lumexa Imaging
0 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

1 Strong Buy rating(s)
3.50
Heartflow
1 Sell rating(s)

2 Hold rating(s)

6 Buy rating(s)

0 Strong Buy rating(s)
2.56
: Lumexa Imaging has a net margin of 0.00% compared to Heartflow's net margin of -66.35%.
Company Net Margins Return on Equity Return on Assets
Lumexa Imaging N/A N/A N/A
Heartflow -66.35% N/A -27.67%
: In the previous week, Heartflow had 9 more articles in the media than Lumexa Imaging. MarketBeat recorded 9 mentions for Heartflow and 0 mentions for Lumexa Imaging. Heartflow's average media sentiment score of 0.32 beat Lumexa Imaging's score of 0.00 indicating that Heartflow is being referred to more favorably in the news media.
Company Overall Sentiment
Lumexa Imaging Neutral
Heartflow Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$267.73M	3.49	N/A	N/A	N/A
Heartflow	$176.03M	14.68	-$116.79M	-$1.99	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
Heartflow	-66.35%	N/A	-27.67%

Company	Overall Sentiment
Lumexa Imaging	Neutral
Heartflow	Neutral

Summary

Lumexa Imaging beats Heartflow on 6 of the 10 factors compared between the two stocks.

How does Lumexa Imaging compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, media sentiment, institutional ownership, risk and earnings.

: 85.5% of LifeStance Health Group shares are held by institutional investors. 6.6% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
: In the previous week, LifeStance Health Group had 6 more articles in the media than Lumexa Imaging. MarketBeat recorded 6 mentions for LifeStance Health Group and 0 mentions for Lumexa Imaging. LifeStance Health Group's average media sentiment score of 0.80 beat Lumexa Imaging's score of 0.00 indicating that LifeStance Health Group is being referred to more favorably in the media.
Company Overall Sentiment
LifeStance Health Group Positive
Lumexa Imaging Neutral
: LifeStance Health Group has a net margin of 0.68% compared to Lumexa Imaging's net margin of 0.00%. LifeStance Health Group's return on equity of 0.65% beat Lumexa Imaging's return on equity.
Company Net Margins Return on Equity Return on Assets
LifeStance Health Group 0.68% 0.65% 0.45%
Lumexa Imaging N/A N/A N/A
: LifeStance Health Group has higher revenue and earnings than Lumexa Imaging.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
LifeStance Health Group $1.42B 2.00 $9.66M $0.02 367.75
Lumexa Imaging $267.73M 3.49 N/A N/A N/A
: LifeStance Health Group presently has a consensus price target of $9.83, suggesting a potential upside of 33.70%. Lumexa Imaging has a consensus price target of $19.00, suggesting a potential upside of 95.27%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Lumexa Imaging is more favorable than LifeStance Health Group.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
1 Hold rating(s)

6 Buy rating(s)

2 Strong Buy rating(s)
3.11
Lumexa Imaging
0 Sell rating(s)

0 Hold rating(s)

1 Buy rating(s)

1 Strong Buy rating(s)
3.50

Company	Overall Sentiment
LifeStance Health Group	Positive
Lumexa Imaging	Neutral

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	0.68%	0.65%	0.45%
Lumexa Imaging	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	2.00	$9.66M	$0.02	367.75
Lumexa Imaging	$267.73M	3.49	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.11
Lumexa Imaging	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50

Summary

LifeStance Health Group beats Lumexa Imaging on 10 of the 13 factors compared between the two stocks.

How does Lumexa Imaging compare to Veracyte?

Veracyte (NASDAQ:VCYT) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, media sentiment, institutional ownership, risk and earnings.

: In the previous week, Veracyte had 6 more articles in the media than Lumexa Imaging. MarketBeat recorded 6 mentions for Veracyte and 0 mentions for Lumexa Imaging. Veracyte's average media sentiment score of 0.49 beat Lumexa Imaging's score of 0.00 indicating that Veracyte is being referred to more favorably in the media.
Company Overall Sentiment
Veracyte Neutral
Lumexa Imaging Neutral
: Veracyte has a net margin of 12.83% compared to Lumexa Imaging's net margin of 0.00%. Veracyte's return on equity of 8.05% beat Lumexa Imaging's return on equity.
Company Net Margins Return on Equity Return on Assets
Veracyte 12.83% 8.05% 7.38%
Lumexa Imaging N/A N/A N/A
: Veracyte has higher revenue and earnings than Lumexa Imaging.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Veracyte $517.15M 5.09 $66.35M $0.83 39.72
Lumexa Imaging $267.73M 3.49 N/A N/A N/A
: Veracyte presently has a consensus price target of $43.83, suggesting a potential upside of 32.95%. Lumexa Imaging has a consensus price target of $19.00, suggesting a potential upside of 95.27%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Lumexa Imaging is more favorable than Veracyte.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veracyte
1 Sell rating(s)
3 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.38
Lumexa Imaging
0 Sell rating(s)

0 Hold rating(s)

1 Buy rating(s)

1 Strong Buy rating(s)
3.50

Company	Overall Sentiment
Veracyte	Neutral
Lumexa Imaging	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Veracyte	12.83%	8.05%	7.38%
Lumexa Imaging	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veracyte	$517.15M	5.09	$66.35M	$0.83	39.72
Lumexa Imaging	$267.73M	3.49	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veracyte	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38
Lumexa Imaging	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50

Summary

Veracyte beats Lumexa Imaging on 8 of the 11 factors compared between the two stocks.

Get Lumexa Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LMRI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LMRI vs. The Competition

Export

Metric	Lumexa Imaging	Services – Health Industry	Services Sector	NASDAQ Exchange
Market Cap	$935.15M	$1.54B	$1.01B	$11.87B
Dividend Yield	N/A	N/A	4.63%	5.21%
P/E Ratio	N/A	31.87	15.71	28.47
Price / Sales	3.49	5.42	23.06	60.94
Price / Cash	N/A	125.50	34.66	36.52
Price / Book	N/A	39.29	6.59	6.67
Net Income	N/A	-$26.94M	$1.76M	$332.53M
7 Day Performance	4.18%	2.91%	1.04%	2.01%
1 Month Performance	4.06%	5.73%	41.76%	9.20%
1 Year Performance	N/A	N/A	-6.46%	39.59%

Lumexa Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LMRI Lumexa Imaging	N/A	$9.73 -4.5%	$19.00 +95.3%	N/A	$935.15M	$267.73M	N/A	4,335
PRVA Privia Health Group	4.0621 of 5 stars	$23.50 -1.5%	$31.31 +33.2%	N/A	$3.00B	$2.12B	138.24	1,226	News Coverage Upcoming Earnings
CON Concentra Group Holdings Parent	4.078 of 5 stars	$23.04 +1.7%	$30.00 +30.2%	N/A	$2.91B	$2.16B	17.72	13,133	Upcoming Earnings Gap Down
HTFL Heartflow	2.8924 of 5 stars	$31.24 -5.1%	$37.67 +20.6%	N/A	$2.82B	$176.03M	N/A	699	Positive News Analyst Forecast
LFST LifeStance Health Group	4.6465 of 5 stars	$6.99 +1.2%	$9.83 +40.7%	N/A	$2.69B	$1.42B	349.67	10,961	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LMRI) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lumexa Imaging (LMRI) Competitors

LMRI vs. PRVA, CON, HTFL, LFST, and VCYT

How does Lumexa Imaging compare to Privia Health Group?

Summary

How does Lumexa Imaging compare to Concentra Group Holdings Parent?

Summary

How does Lumexa Imaging compare to Heartflow?

Summary

How does Lumexa Imaging compare to LifeStance Health Group?

Summary

How does Lumexa Imaging compare to Veracyte?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMRI vs. The Competition

Lumexa Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lumexa Imaging (LMRI) Competitors

LMRI vs. PRVA, CON, HTFL, LFST, and VCYT

How does Lumexa Imaging compare to Privia Health Group?

Summary

How does Lumexa Imaging compare to Concentra Group Holdings Parent?

Summary

How does Lumexa Imaging compare to Heartflow?

Summary

How does Lumexa Imaging compare to LifeStance Health Group?

Summary

How does Lumexa Imaging compare to Veracyte?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMRI vs. The Competition

Lumexa Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools